{"id":534472,"date":"2021-09-03T18:03:04","date_gmt":"2021-09-03T22:03:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/"},"modified":"2021-09-03T18:03:04","modified_gmt":"2021-09-03T22:03:04","slug":"atai-life-sciences-to-participate-in-upcoming-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/","title":{"rendered":"atai Life Sciences to Participate in Upcoming September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BERLIN, Sept.  03, 2021  (GLOBE NEWSWIRE) &#8212; atai Life Sciences N.V. (Nasdaq: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,\u00a0today announced that it will participate in in the following upcoming investor conferences in September:<\/p>\n<p>Presentation details can be found below:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Citi 16<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual BioPharma Conference<\/strong><br \/>\n          <br \/>Format: Panel Discussion<br \/>Date and Time: Wednesday, September 8<sup>th<\/sup>, 2021, 2:20 p.m. ET<br \/>Webcast Link: https:\/\/kvgo.com\/citi-16th-annual-biopharma-vc\/panel-atai-life-sciences-sept-2021<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>H.C. Wainwright 23<\/strong><br \/>\n          <sup><br \/>\n            <strong>rd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Investment Conference<\/strong><br \/>\n          <br \/>Format: Presentation<br \/>Date and Time: Monday, September 13<sup>th<\/sup>, 2021, 9:00 a.m. ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Baader Investment Conference (BIC)<\/strong><br \/>\n          <br \/>Format: Presentation<br \/>Date and Time: Tuesday, September 21<sup>st<\/sup>, 2021, 11:30 a.m. ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Cantor Fitzgerald Global Healthcare Conference<\/strong><br \/>\n          <br \/>Format: Fireside Chat<br \/>Date and Time: Monday, September 27<sup>th<\/sup>, 2021, 10:00 a.m. ET<br \/>Webcast Link: https:\/\/wsw.com\/webcast\/cantor12\/atai\/2059190<\/li>\n<\/ul>\n<p>The presentations and archived webcasts will also be accessible in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-78ohTt2pUsMm4oGYKc07Y1LNaOXMWLLx14thQjs7T2ClB0aTCQE-KOVdV3H6A36_0zoRXckTNqYNyAyloaGD-CbcjAMR78bgpUDNG7KD04=\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a>\u00a0section of atai\u2019s website.<\/p>\n<p>\n        <strong>About atai Life Sciences<\/strong><\/p>\n<p>atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to acquiring, incubating and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. atai&#8217;s business model combines funding, technology, scientific and regulatory expertise with a focus on psychedelic therapy and other drugs with differentiated safety profiles and therapeutic potential. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies, seeking to effectively treat and ultimately heal mental health disorders. atai&#8217;s mission is to bridge the gap between what the mental healthcare system currently provides and what patients need. atai is headquartered in Berlin, with offices in New York and London. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JcjayobSwtSE9a7wAfASaXm0afiKFXvFqJ1X058fdwCPVXH_15olF-8ZRggCb8LjjCdtapat_sbiT4Nfw73ap7AVYNr0C7vXWXUyIxXvTQQwupvXGCmSYubS30MFgvvKfcHl2W8zqh0oHfZsCO5Am0GTc5F4tA6MX-A0nWLXAlhO2pX7OtCDx2Btmgk7c3HkN-LbJfwC28FxMQZ9uA-xpJMW9C-z8Un_ALPkaQu7oJPK5mXxNcoQbMwOR0N3sn8zO6teTeSRFmwrRkSTM2StpHXljjtswlYWDheqJnvb6k6Uy1N8uCMq5GoBCU9-kck-u_zb2iFtcFhtN8mmqamFXFEAYvTbKM0h_cKaKQdVY34=\" rel=\"nofollow noopener\" target=\"_blank\">www.atai.life<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation, the important factors discussed under the caption \u201cRisk Factors\u201d in atai&#8217;s prospectus pursuant to Rule 424(b) filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) on June 21, 2021, as such factors may be updated from time to time in atai&#8217;s other filings with the SEC. atai disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by applicable law.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Greg Weaver<br \/>atai \u2013 Chief Financial Officer<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HSh7_eC79BxBD_x8i6AaSMFGjDfg_ole9UgXK9wRUhff2q6JL9gfZks2irxp3GJTbN_VHuSBWvM17gMB-5Kx9IMjGxDfVgV3DwEwzadmL-w=\" rel=\"nofollow noopener\" target=\"_blank\">greg.weaver@atai.life<\/a>\u00a0<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Anne Donohoe<br \/>KCSA Strategic Communications<br \/>Phone: +1 (212) 896-1265<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=71fdxlU0p8YIlxzYIcjbmD1rwp_bsYAQAEMaXfoo8wpBTy81a78EcOuCIvP_VUarUnS5HtybQ2o96kvru-5r2g==\" rel=\"nofollow noopener\" target=\"_blank\">atai@KCSA.com<\/a>\u00a0<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZmRlNTJhYWItOTRkNS00NzFlLTk3NzMtYmFiMDA0ZmEwMDE3LTEyMTgxNDI=\/tiny\/Atai-Life-Sciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BERLIN, Sept. 03, 2021 (GLOBE NEWSWIRE) &#8212; atai Life Sciences N.V. (Nasdaq: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,\u00a0today announced that it will participate in in the following upcoming investor conferences in September: Presentation details can be found below: Citi 16 th Annual BioPharma Conference Format: Panel DiscussionDate and Time: Wednesday, September 8th, 2021, 2:20 p.m. ETWebcast Link: https:\/\/kvgo.com\/citi-16th-annual-biopharma-vc\/panel-atai-life-sciences-sept-2021 H.C. Wainwright 23 rd Annual Global Investment Conference Format: PresentationDate and Time: Monday, September 13th, 2021, 9:00 a.m. ET Baader Investment Conference (BIC) Format: PresentationDate and Time: Tuesday, September 21st, 2021, 11:30 a.m. ET Cantor Fitzgerald Global Healthcare Conference Format: Fireside ChatDate and Time: Monday, September 27th, 2021, 10:00 a.m. ETWebcast Link: https:\/\/wsw.com\/webcast\/cantor12\/atai\/2059190 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;atai Life Sciences to Participate in Upcoming September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534472","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>atai Life Sciences to Participate in Upcoming September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"atai Life Sciences to Participate in Upcoming September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BERLIN, Sept. 03, 2021 (GLOBE NEWSWIRE) &#8212; atai Life Sciences N.V. (Nasdaq: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,\u00a0today announced that it will participate in in the following upcoming investor conferences in September: Presentation details can be found below: Citi 16 th Annual BioPharma Conference Format: Panel DiscussionDate and Time: Wednesday, September 8th, 2021, 2:20 p.m. ETWebcast Link: https:\/\/kvgo.com\/citi-16th-annual-biopharma-vc\/panel-atai-life-sciences-sept-2021 H.C. Wainwright 23 rd Annual Global Investment Conference Format: PresentationDate and Time: Monday, September 13th, 2021, 9:00 a.m. ET Baader Investment Conference (BIC) Format: PresentationDate and Time: Tuesday, September 21st, 2021, 11:30 a.m. ET Cantor Fitzgerald Global Healthcare Conference Format: Fireside ChatDate and Time: Monday, September 27th, 2021, 10:00 a.m. ETWebcast Link: https:\/\/wsw.com\/webcast\/cantor12\/atai\/2059190 &hellip; Continue reading &quot;atai Life Sciences to Participate in Upcoming September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-03T22:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"atai Life Sciences to Participate in Upcoming September Investor Conferences\",\"datePublished\":\"2021-09-03T22:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/\"},\"wordCount\":474,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/\",\"name\":\"atai Life Sciences to Participate in Upcoming September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=\",\"datePublished\":\"2021-09-03T22:03:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"atai Life Sciences to Participate in Upcoming September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"atai Life Sciences to Participate in Upcoming September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"atai Life Sciences to Participate in Upcoming September Investor Conferences - Market Newsdesk","og_description":"BERLIN, Sept. 03, 2021 (GLOBE NEWSWIRE) &#8212; atai Life Sciences N.V. (Nasdaq: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,\u00a0today announced that it will participate in in the following upcoming investor conferences in September: Presentation details can be found below: Citi 16 th Annual BioPharma Conference Format: Panel DiscussionDate and Time: Wednesday, September 8th, 2021, 2:20 p.m. ETWebcast Link: https:\/\/kvgo.com\/citi-16th-annual-biopharma-vc\/panel-atai-life-sciences-sept-2021 H.C. Wainwright 23 rd Annual Global Investment Conference Format: PresentationDate and Time: Monday, September 13th, 2021, 9:00 a.m. ET Baader Investment Conference (BIC) Format: PresentationDate and Time: Tuesday, September 21st, 2021, 11:30 a.m. ET Cantor Fitzgerald Global Healthcare Conference Format: Fireside ChatDate and Time: Monday, September 27th, 2021, 10:00 a.m. ETWebcast Link: https:\/\/wsw.com\/webcast\/cantor12\/atai\/2059190 &hellip; Continue reading \"atai Life Sciences to Participate in Upcoming September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-03T22:03:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"atai Life Sciences to Participate in Upcoming September Investor Conferences","datePublished":"2021-09-03T22:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/"},"wordCount":474,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/","name":"atai Life Sciences to Participate in Upcoming September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=","datePublished":"2021-09-03T22:03:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE2MiM0Mzg4ODQ5IzIyMDY1ODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-upcoming-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"atai Life Sciences to Participate in Upcoming September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534472"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534472\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}